Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengzhu Zheng

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Organic Letters|December 18, 2023
Site-Selective Synthesis of Antitumor C5-Aminated Indoles via Neighboring Aldehyde Group Assisted Catellani ReactionGuangyuan Liu, Mengzhu Zheng, Rong Tian, et al.
Biochemical Pharmacology|March 14, 2026
Therapeutic targeting of tricarboxylic acid cycle and oxidative phosphorylation: a critical analysis of metabolic interventions in cancer treatmentYawei Han, Yuhao Wei, Yuanting Xie, et al.
Microbiological Research|June 6, 2022
The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018Xiaoxia Gu, Mengzhu Zheng, Lixia Chen, et al.
International Immunopharmacology|December 24, 2017
The dual regulatory function of lienal peptide on immune systemJing Wang, Mengzhu Zheng, Qiuxia Min, et al.
Future Medicinal Chemistry|March 17, 2022
Proteolysis-targeting chimera molecules targeting SHP2Dandan Yu, Mengzhu Zheng, Yang Liu, et al.
Bioorganic Chemistry|March 11, 2019
Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenaseJing Guo, Xiaoxia Gu, Mengzhu Zheng, et al.
European Journal of Pharmacology|December 21, 2025
Recent advances in antitumor indole-chalcone derivatives: a mini reviewGuangyuan Liu, Yawei Han, Yuhao Wei, et al.
Bioorganic Chemistry|May 9, 2018
Steroids from Ganoderma sinense as new natural inhibitors of cancer-associated mutant IDH1Mengzhu Zheng, Ruotian Tang, Yue Deng, et al.
European Journal of Pharmacology|January 10, 2022
Glutamic oxaloacetic transaminase 1 as a potential target in human cancerZhuorui Song, Yueying Yang, Yanli Wu, et al.
Medcomm|March 10, 2025
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and InterventionsHuimin Yuan, Ruochen Xu, Senlin Li, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Organic Letters|December 18, 2023
Site-Selective Synthesis of Antitumor C5-Aminated Indoles via Neighboring Aldehyde Group Assisted Catellani ReactionGuangyuan Liu, Mengzhu Zheng, Rong Tian, et al.
Biochemical Pharmacology|March 14, 2026
Therapeutic targeting of tricarboxylic acid cycle and oxidative phosphorylation: a critical analysis of metabolic interventions in cancer treatmentYawei Han, Yuhao Wei, Yuanting Xie, et al.
Microbiological Research|June 6, 2022
The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018Xiaoxia Gu, Mengzhu Zheng, Lixia Chen, et al.
International Immunopharmacology|December 24, 2017
The dual regulatory function of lienal peptide on immune systemJing Wang, Mengzhu Zheng, Qiuxia Min, et al.
Future Medicinal Chemistry|March 17, 2022
Proteolysis-targeting chimera molecules targeting SHP2Dandan Yu, Mengzhu Zheng, Yang Liu, et al.
Bioorganic Chemistry|March 11, 2019
Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenaseJing Guo, Xiaoxia Gu, Mengzhu Zheng, et al.
European Journal of Pharmacology|December 21, 2025
Recent advances in antitumor indole-chalcone derivatives: a mini reviewGuangyuan Liu, Yawei Han, Yuhao Wei, et al.
Bioorganic Chemistry|May 9, 2018
Steroids from Ganoderma sinense as new natural inhibitors of cancer-associated mutant IDH1Mengzhu Zheng, Ruotian Tang, Yue Deng, et al.
European Journal of Pharmacology|January 10, 2022
Glutamic oxaloacetic transaminase 1 as a potential target in human cancerZhuorui Song, Yueying Yang, Yanli Wu, et al.
Medcomm|March 10, 2025
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and InterventionsHuimin Yuan, Ruochen Xu, Senlin Li, et al.
Pageof 5